Lineage Cell Therapeutics
LCTX
$1.05
Share price
-7.08%
Change (1 day)
-22.79%
Change (1 year)
Categories
Lineage Cell Therapeutics (LCTX) - Cash on Hand
Cash on Hand as of December 2023 : $35.49 M
According to Lineage Cell Therapeutics
's latest financial reports the company has $35.49 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Lineage Cell Therapeutics - Cash on Hand chart (from 2001 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $35.49 M | -38.67% |
| 2022-12-31 | $57.87 M | -0.83% |
| 2021-12-31 | $58.35 M | 40.41% |
| 2020-12-31 | $41.56 M | 35.31% |
| 2019-12-31 | $30.71 M | -0.08% |
| 2018-12-31 | $30.74 M | -19.47% |
| 2017-12-31 | $38.17 M | 68.06% |
| 2016-12-31 | $22.71 M | -47.15% |
| 2015-12-31 | $42.98 M | 45.75% |
| 2014-12-31 | $29.49 M | 436.62% |
| 2013-12-31 | $5.49 M | 26.33% |
| 2012-12-31 | $4.34 M | -80.42% |
| 2011-12-31 | $22.21 M | -33.35% |
| 2010-12-31 | $33.32 M | 173.4% |
| 2009-12-31 | $12.18 M | 99167.7% |
| 2008-12-31 | $0.01 M | 29.24% |
| 2007-12-31 | $0 M | -98.31% |
| 2006-12-31 | $0.56 M | -69.41% |
| 2005-12-31 | $1.83 M | 33.78% |
| 2004-12-31 | $1.37 M | 91.13% |
| 2003-12-31 | $0.71 M | -44.16% |
| 2002-12-31 | $1.28 M | -22.29% |
| 2001-12-31 | $1.65 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.20 B | 486.57% | 🇺🇸 USA |